Maynard Ryan D
SEC insider (Form 3/4/5 filer). CIK 0001363984. Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SAN CARLOS, CA.
Companies Maynard Ryan D has filed insider reports for
- IOVANCE BIOTHERAPEUTICS, INC. (IOVA): Director
- Foghorn Therapeutics Inc. (FHTX): Officer, Chief Financial Officer
Maynard Ryan D
CIK: 0001363984
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 16, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectDeferred Restricted Stock Unit
90.3K shares- - Feb 23, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
400K shares at avg. $5.75- - Jun 13, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectDeferred Restricted Stock Unit
67.5K shares- - Nov 12, 2024IOVA
IOVANCE BIOTHERAPEUTICS, INC.
ExerciseDirect50K shares at avg. $7.45$373K - Nov 12, 2024IOVA
IOVANCE BIOTHERAPEUTICS, INC.
SaleDirect50K shares at avg. $10.06$503K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Deferred Restricted Stock Unit | 90,316 | - | - | Direct |
| Feb 23, 2026 |  FHTX Foghorn Therapeutics Inc. | Award Stock Option (right to buy) | 400,000 | $5.75 | - | Direct |
| Jun 13, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Deferred Restricted Stock Unit | 67,546 | - | - | Direct |
| Nov 12, 2024 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise | 50,000 | $7.45 | $372,500 | Direct |
| Nov 12, 2024 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Sale | 50,000 | $10.06 | $503,000 | Direct |
1-5 of 5 transactions